Health Sep 07

Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. Photo by Andrew Kelly/REUTERS
FDA panel backs much-debated ALS drug in rare turnaround

A panel of federal health advisers voted Wednesday to recommend approval for an experimental drug to treat Lou Gehrig’s disease, a remarkable turnaround for the much-debated medication that was previously rejected by the same group.

Health Mar 30

Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. Photo by Andrew Kelly/REUTERS
FDA panel narrowly rejects experimental ALS drug

Wednesday's vote by the Food and Drug Administration expert panel is a potential setback for patient groups who have lobbied for the medication's approval for ALS for more than a year.